Similar articles for PMID: 25324522

Year	Number of Results
1965	1
1995	1
1999	1
2002	1
2005	6
2006	1
2007	5
2008	3
2009	5
2010	10
2011	13
2012	8
2013	10
2014	12
2015	8
2016	8
2017	7
2018	5
2019	2
2020	5
2021	1
2024	0

1

Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients.

Verwer EE, Bahce I, van Velden FH, Yaqub M, Schuit RC, Windhorst AD, Raijmakers P, Hoekstra OS, Lammertsma AA, Smit EF, Boellaard R. Verwer EE, et al. J Nucl Med. 2014 Nov;55(11):1772-7. doi: 10.2967/jnumed.114.141846. Epub 2014 Oct 16. J Nucl Med. 2014. PMID: 25324522 Free article.

2

Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with ¹⁸F-Fluoroazomycin Arabinoside and ¹⁵O-H₂O PET.

Iqbal R, Kramer GM, Verwer EE, Huisman MC, de Langen AJ, Bahce I, van Velden FH, Windhorst AD, Lammertsma AA, Hoekstra OS, Boellaard R. Iqbal R, et al. J Nucl Med. 2016 Apr;57(4):530-5. doi: 10.2967/jnumed.115.166579. Epub 2015 Dec 10. J Nucl Med. 2016. PMID: 26659349 Free article.

3

Parametric Method Performance for Dynamic 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy.

Kramer GM, Frings V, Heijtel D, Smit EF, Hoekstra OS, Boellaard R; QuIC-ConCePT Consortium. Kramer GM, et al. J Nucl Med. 2017 Jun;58(6):920-925. doi: 10.2967/jnumed.116.178418. Epub 2016 Nov 10. J Nucl Med. 2017. PMID: 28572289 Free article. Clinical Trial.

4

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Verwer EE, van Velden FH, Bahce I, Yaqub M, Schuit RC, Windhorst AD, Raijmakers P, Lammertsma AA, Smit EF, Boellaard R. Verwer EE, et al. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1523-31. doi: 10.1007/s00259-013-2462-3. Epub 2013 Jun 6. Eur J Nucl Med Mol Imaging. 2013. PMID: 23740374

5

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.

Bollineni VR, Kerner GS, Pruim J, Steenbakkers RJ, Wiegman EM, Koole MJ, de Groot EH, Willemsen AT, Luurtsema G, Widder J, Groen HJ, Langendijk JA. Bollineni VR, et al. J Nucl Med. 2013 Aug;54(8):1175-80. doi: 10.2967/jnumed.112.115014. Epub 2013 Jun 10. J Nucl Med. 2013. PMID: 23753185 Free article.

6

First Evaluation of PET-Based Human Biodistribution and Dosimetry of ¹⁸F-FAZA, a Tracer for Imaging Tumor Hypoxia.

Savi A, Incerti E, Fallanca F, Bettinardi V, Rossetti F, Monterisi C, Compierchio A, Negri G, Zannini P, Gianolli L, Picchio M. Savi A, et al. J Nucl Med. 2017 Aug;58(8):1224-1229. doi: 10.2967/jnumed.113.122671. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209906 Free article.

7

Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.

van der Veldt AA, Hendrikse NH, Harms HJ, Comans EF, Postmus PE, Smit EF, Lammertsma AA, Lubberink M. van der Veldt AA, et al. J Nucl Med. 2010 Nov;51(11):1684-90. doi: 10.2967/jnumed.110.079137. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956480 Free article. Clinical Trial.

8

Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.

Bollineni VR, Koole MJ, Pruim J, Brouwer CL, Wiegman EM, Groen HJ, Vlasman R, Halmos GB, Oosting SF, Langendijk JA, Widder J, Steenbakkers RJ. Bollineni VR, et al. Radiother Oncol. 2014 Nov;113(2):198-203. doi: 10.1016/j.radonc.2014.10.010. Epub 2014 Nov 27. Radiother Oncol. 2014. PMID: 25434768

9

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.

Trinkaus ME, Blum R, Rischin D, Callahan J, Bressel M, Segard T, Roselt P, Eu P, Binns D, MacManus MP, Ball D, Hicks RJ. Trinkaus ME, et al. J Med Imaging Radiat Oncol. 2013 Aug;57(4):475-81. doi: 10.1111/1754-9485.12086. Epub 2013 Jun 14. J Med Imaging Radiat Oncol. 2013. PMID: 23870348 Clinical Trial.

10

Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.

Verwer EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, Windhorst AD, Schwarte LA, Hendrikse NH, Schuit RC, Hoekstra OS, Lammertsma AA, Boellaard R. Verwer EE, et al. J Nucl Med. 2015 Mar;56(3):365-71. doi: 10.2967/jnumed.114.148007. Epub 2015 Feb 12. J Nucl Med. 2015. PMID: 25678491 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year